Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
[4] [5] The three primary subcutaneous injection sites used for comparable licensed therapies (such as semaglutide and tirzepatide, as described in their UK Summary of Product Characteristics) are: Abdomen the area around the stomach, avoiding the area immediately around the navel Front (anterolateral) thigh the outer-front portion of the upper thigh Upper arms the outer area of the upper arm, typically requiring assistance from another person for self-administration The abdomen is generally considered the most accessible and commonly used site, as it offers a relatively large surface area of subcutaneous fat and is straightforward to self-administer
Always consult a qualified healthcare provider before starting any treatment.
Now, if you're new here
Do not leave syringes at room temperature
(Carbiab) What the Clinical Trials Say About Tirzepatide Clinical trials have demonstrated Tirzepatides superior efficacy in managing blood glucose levels and facilitating weight loss
Released Tuesday, its the largest-ever study done, real-world evidence study of the medication, Hashmi said
